Tecentriq Linked to LEMS in Man With Non-Small Lung Cancer
A possible first case of a man with non-small cell lung cancer (NSCLC) developing Lambert-Eaton myasthenic syndrome (LEMS) after being treated with Tecentriq (atezolizumab) has been reported in Pennsylvania. This case adds to prior evidence linking the use of Tecentriq, as well as the immunotherapies Opdivo and…